Erika M. Moore, MD
Assistant Professor of Pathology



Dr. Erika M. Moore is a member of the Division of Hematopathology.







Office Location:
Hill Building 3rd Floor, Rm #357
3477 Euler Way
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-647-4162
Fax: 412-647-4008
Email: erikamoore@upmc.edu

Education

  • MD - University of Pennsylvania School of Medicine, 2010
  • Residency - Hospital of the University of Pennsylvania, 2010-2014
  • Fellowship - Hematopathology, University of Pittsburgh Medical Center, 2014-2015

Research Interests

Dr. Moore's research interests include further characterization of hematopoietic neoplasms using immunohistochemistry, flow cytometry, and genetic studies, as well as integration of clinical prognostic and therapeutic information. She is particularly interested in B-cell lymphomas but also studies myeloid neoplasms. Recent and ongoing projects include evaluation of the flow cytometric and genetic characteristics of myelodysplastic/myeloproliferative neoplasms, unclassifiable, review of the pathologic and clinical characteristics of patients who have significant bone marrow involvement by a chronic lymphocytic leukemia/small lymphocytic lymphoma-like B-cell proliferation but who do not meet diagnostic criteria for lymphoma, and assessment of MEF2B immunohistochemistry in mantle cell lymphomas.

Selected Publications

  1. Moore EM, Swerdlow SH, Gibson SE. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas. Am J Surg Pathol. 2018 Mar;42(3):342-350.
  2. Moore EM, Swerdlow SH, Gibson SE. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Hum Pathol. 2017 Oct;68:47-53.
  3. Moore EM, Aggarwal N, Surti U, Swerdlow SH. Further exploration of the complexities of large B-cell lymphomas with MYC abnormalities and the importance of a blastoid morphology. Am J Surg Pathol. 2017 Sep;41(9):1155-1166.
  4. Tashkandi H, Moore EM, Tomlinson B, Goebel T, Sadri N. Co-occurrence of Type I CALR and Two MPL Mutations in Patient with Primary Myelofibrosis. Annals of Hematology. 2017 Aug;96(8):1417-1418.
  5. Moore EM, Roth CG. Plasma cell leukemia mimicking acute myeloid leukemia. Blood. 2016 May;127(19):2359.